A Long-term Extension Study of JNJ-77242113 in Participants With Moderate-to-Severe Plaque Psoriasis

Clinical trial NCT05364554 · COMPLETED

Trial details

NCT number: NCT05364554
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Plaque Psoriasis

Start date: 2022-06-10
Primary completion: 2023-09-29
Enrollment: 227

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.